OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TP53 in bone and soft tissue sarcomas
Elizabeth Thoenen, Amanda Curl, Tomoo Iwakuma
Pharmacology & Therapeutics (2019) Vol. 202, pp. 149-164
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Targeting strategies for bone diseases: signaling pathways and clinical studies
Hao Xu, Wentao Wang, Xin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 61

Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
Shenglong Li
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 63

Origin and Therapies of Osteosarcoma
Brice Moukengué, Morgane Lallier, Louise Marchandet, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3503-3503
Open Access | Times Cited: 50

Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
Jun‐Ho Kim, Seul Ki Lee
Cancers (2023) Vol. 15, Iss. 6, pp. 1703-1703
Open Access | Times Cited: 41

Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors
Yao Xu, Fanqi Shi, Yanting Zhang, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 2, pp. 226-240
Closed Access | Times Cited: 23

Primary Hepatocellular Carcinosarcoma: A Case Series and Literature Review
Hailong Qiao, Huaibin Guo, Ze Liang, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102520-102520
Closed Access | Times Cited: 1

TP53 in Biology and Treatment of Osteosarcoma
Kamil Synoradzki, Ewa Bartnik, Anna M. Czarnecka, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4284-4284
Open Access | Times Cited: 44

Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
Chin Sern Yiong, Tzu Ping Lin, Vivian Lim, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 17

CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
Monserrat Gerardo‐Ramírez, Friederike Keggenhoff, Vanessa Giam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8616-8616
Open Access | Times Cited: 26

Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
Fan Tang, Yan Tie, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188606-188606
Open Access | Times Cited: 31

Radiotherapy in bone sarcoma: the quest for better treatment option
Marie-Anaïs Locquet, Mehdi Brahmi, Jean‐Yves Blay, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Undifferentiated small round cell sarcoma of the parapharyngeal space in a 4.5-year-old patient:A rare case report
Lei Wang, Xiao-Jian Kang
Oral Oncology (2025) Vol. 161, pp. 107184-107184
Closed Access

Tetrahydrocurcumin-induced apoptosis of hepatocellular carcinoma cells involves the TP53 signaling pathway, as determined by network pharmacology
Zhiwei Bao, Zhang Ye, Zhaodong Liu, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 3
Closed Access

Primary giant liposarcoma of the gallbladder: a case report and literature review
Yu Yang, Yingyong Hou, Yi Li, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access

Renal ewing sarcoma in a young female: a case report and review of targeted therapy
Pengfei Wang, M. K. H. Wang, Jennifer Zhan, et al.
Frontiers in Surgery (2025) Vol. 12
Open Access

Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility
Isaak Ailts, Michael A. Golafshar, Katie L. Kunze, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2839-2839
Open Access

Exploring the Potential of Optical Genome Mapping in the Diagnosis and Prognosis of Soft Tissue and Bone Tumors
Alejandro Berenguer-Rubio, Esperanza Such, Neus Torres Hernández, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2820-2820
Open Access

Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care
Agnes Ewongwo, Caressa Hui, Everett J. Moding
Seminars in Radiation Oncology (2024) Vol. 34, Iss. 2, pp. 195-206
Closed Access | Times Cited: 3

A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations
Timothy I. Miller, Nicholas A. Zoumberos, Bryan Johnson, et al.
Human Pathology (2020) Vol. 102, pp. 60-69
Closed Access | Times Cited: 27

DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma
Forough Alemi, Faezeh Malakoti, Mostafa Vaghari‐Tabari, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 5, pp. 2374-2386
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top